Cancer

C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors

Hoerter Brings Over Three Decades of Oncology Commercialization and Leadership Experience Appointment Underscores Continued Transformation of Board to Lead C4T…

1 year ago

VitalHub announces SHREWD implementation with Winnipeg Regional Health Authority

TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to…

1 year ago

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than…

1 year ago

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee 

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the…

1 year ago

Press Release: Sequana Medical announces Extraordinary General Meeting of Shareholders on 20 December 2024

Sequana Medical announces Extraordinary General Meeting of Shareholders on 20 December 2024 Ghent, Belgium – 20 November 2024 – Sequana…

1 year ago

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

BioTech Company of the Year Cytek Biosciences has been named “Overall BioTech Company of the Year” in the fourth annual…

1 year ago

GRAIL to Participate in Upcoming Investor Conferences

MENLO PARK, Calif., Nov. 19, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect…

1 year ago

CareMessage Introduces AI Assistant to Close Health Equity Gaps in Underserved Communities

AI Assistant projected to save healthcare providers $5M annually by reducing patient no-show rates SAN FRANCISCO, Nov. 19, 2024 /PRNewswire/…

1 year ago